{"id":"W4406810524","doi":"10.1016/j.kint.2024.11.013","title":"Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","year":2025,"lang":"en","type":"article","venue":"Kidney International","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health; University of Pennsylvania; OPKO Health; Vertex Pharmaceuticals; Menarini Group; Korean Society of Nephrology; Ono Pharmaceutical; Fresenius Medical Care North America; Astellas Pharma; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Nierstichting; European Commission; Kissei; Inozyme Pharma; Torii Pharmaceutical; Amicus Therapeutics; Alexion Pharmaceuticals; International Osteoporosis Foundation; American Society of Nephrology; Intas Pharmaceuticals; AstraZeneca; Hong Kong Society of Nephrology; Amgen; Kidney Disease: Improving Global Outcomes","keywords":"Kidney disease; Medicine; Disease; Kidney; Bone disease; Internal medicine; Intensive care medicine; Osteoporosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04457793,0.002323436,0.003302801,0.003085965,0.002720034,0.009057151,0.004560788,0.01530538,0.007092599],"category_scores_gemma":[0.05637618,0.0006916912,0.005867316,0.004208414,0.002765029,0.006461377,0.00956289,0.02287162,0.002264967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007626047,"about_ca_system_score_gemma":0.04460609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02274184,"about_ca_topic_score_gemma":0.03692747,"domain_scores_codex":[0.9863637,0.004078359,0.002074709,0.000978751,0.004804943,0.001699501],"domain_scores_gemma":[0.9504004,0.02200249,0.003016294,0.001003874,0.0165798,0.006997134],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00044854,0.000122518,0.001583863,0.002873336,0.00049811,0.00009318465,0.0003081348,0.0002572442,0.0001318246,0.01198711,0.9063702,0.07532596],"study_design_scores_gemma":[0.0006368043,0.0001110394,0.007131001,0.01485756,0.001959826,0.00009269881,0.001331597,0.0002419823,0.0004049497,0.01630701,0.9567845,0.0001410688],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.0007197824,0.07638341,0.0003996178,0.8783485,0.03796605,0.00006989946,0.001733827,0.00004095754,0.004337949],"genre_scores_gemma":[0.01841164,0.1323168,0.004769224,0.7808727,0.05490178,0.0004358183,0.00437063,0.0001413781,0.003780013],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.04457793,"threshold_uncertainty_score":0.2357535,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007703520937452834,"score_gpt":0.2828709671059757,"score_spread":0.2751674461685228,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}